Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Versant Venture Capital V, L.p.


  • at Aprea Therapeutics Inc. (APRE), 2019-10-07
  • Large Shareholder at Crinetics Pharmaceuticals Inc. (CRNX), 2019-02-06
  • Large Shareholder at Gritstone Oncology Inc. (GRTS), 2018-10-02
  • Large Shareholder at Crispr Therapeutics Ag (CRSP), 2018-04-26
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CRSP $51.00 1,528 Large Shareholder 115,645 2018-04-24 Filing
CRSP $51.00 653 Large Shareholder 49,419 2018-04-24 Filing
CRSP $50.60 589 Large Shareholder 44,582 2018-04-24 Filing
CRSP $51.00 20,071 Large Shareholder 1,519,505 2018-04-24 Filing